RecruitingPhase 1

Serum Collection Study for Assay Development

Australia12 participantsStarted 2025-10

Plain-language summary

The study will collect serum from 12 participants vaccinated with Gamma-PN to assist with assay development and validation

Age range18 Years – 69 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * good general health Exclusion Criteria: * no previous pneumococcal vaccine

OPA

Timeframe: 6 months

NCT IDNCT07205289

SponsorGPN Vaccines

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2026-01

Nerissa Lakhan, PhD